| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
5,113,473 | 4,509,587 | 3,551,607 | 3,327,700 | 3,138,053 |
| Cost of Revenue
|
-3,286,524 | -2,974,768 | -2,528,305 | -2,571,184 | -2,306,263 |
|
Gross Profit
|
1,826,949 | 1,534,819 | 1,023,302 | 756,516 | 831,790 |
| Selling, General and Administrative Expenses
|
-522,960 | -467,713 | -419,543 | -398,147 | -380,475 |
|
Research and Development Expenses
|
-96,630 | -97,288 | -69,086 | -128,948 | -143,324 |
|
Operating Income/Expenses
|
-619,590 | -565,001 | -488,629 | -527,095 | -523,799 |
|
Total Operating Profit/Loss
|
1,207,359 | 969,818 | 534,673 | 229,421 | 307,991 |
| Total Net Finance Income/Expense
|
-52,443 | -43,033 | -36,152 | -52,720 | -27,687 |
| Net Investment Income
|
0 | -- | 0 | -3,415 | -23,800 |
| Irregular Income/Expenses
|
-- | -- | -- | -- | 0 |
|
Other Income/Expense, Non-Operating
|
43,158 | -45,086 | 60,424 | 176,751 | 116,155 |
|
Non-Operating Income/Expenses, Total
|
-9,285 | -88,119 | 24,272 | 120,616 | 64,668 |
|
Pretax Income
|
1,198,074 | 881,699 | 558,945 | 350,037 | 372,659 |
|
Provision for Income Tax
|
-177,157 | -125,121 | -67,043 | -38,043 | -47,408 |
|
Net Income from Continuing Operations
|
1,020,917 | 756,578 | 491,902 | 311,994 | 325,251 |
|
Discontinued Operations
|
-- | -- | -- | -- | 0 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
1,020,917 | 756,578 | 491,902 | 311,994 | 325,251 |
|
Non-Controlling/Minority Interests
|
-- | -- | -- | -- | 0 |
|
Net Income after Non-Controlling/Minority Interests
|
1,020,917 | 756,578 | 491,902 | 311,994 | 325,251 |
|
Net Income Available to Common Stockholders
|
1,020,917 | 756,578 | 491,902 | 311,994 | 325,251 |
|
Diluted Net Income Available to Common Stockholders
|
1,020,917 | 756,578 | 491,902 | 311,994 | 325,251 |
| Basic EPS
|
5.78 | 4.37 | 2.85 | 2.02 | 2.17 |
| Diluted EPS
|
5.55 | 4.19 | 2.84 | 2.00 | 2.06 |
|
Basic Weighted Average Shares Outstanding
|
176,208.96 | 173,129.98 | 172,597.19 | 154,452.48 | 149,885.25 |
|
Diluted Weighted Average Shares Outstanding
|
182,728.41 | 180,567.54 | 173,204.93 | 155,997 | 157,888.84 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
1,250,517 | 924,732 | 595,097 | 402,757 | 400,346 |
|
EBITDA
|
2,298,218 | 1,879,424 | 1,453,039 | 1,215,909 | 1,003,362 |
|
Normalized EBITDA
|
2,292,871 | 1,870,595 | 1,437,374 | 1,063,139 | 939,282 |
|
Normalized Income
|
1,016,360.65 | 749,001.91 | 478,115.95 | 175,827.50 | 269,322.94 |
12/31/2022 - 12/31/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade